loading page

Future options to reduce RhD immunization in addition to a high coverage prevention program of antenatal and postnatal RhIg: a nationwide cohort study
  • +4
  • Yolentha Slootweg,
  • Carolien Zwiers,
  • Johanna Koelewijn,
  • Ellen van der Schoot,
  • Dick Oepkes,
  • Inge Kamp,
  • Masja de Haas
Yolentha Slootweg
Leiden University Medical Center
Author Profile
Carolien Zwiers
Leiden Universitair Medisch Centrum
Author Profile
Johanna Koelewijn
Sanquin Research
Author Profile
Ellen van der Schoot
Sanquin Research
Author Profile
Dick Oepkes
Leiden University Medical Centre
Author Profile
Inge Kamp
Leiden Universitair Medisch Centrum
Author Profile
Masja de Haas
Sanquin Research Clinical Transfusion Research
Author Profile

Abstract

Objective: To evaluate which risk factors for RhD immunization remain, despite adequate routine antenatal and postnatal RhIg prophylaxis (1000 IU RhIg) and additional administration of RhIg. Assessment of the prevalence of RhD immunizations. Design: Prospective cohort Setting: The Netherlands. Population: Two-year nationwide cohort. Methods: RhD-negative women in their first RhD immunized pregnancy and their foregoing non-immunized pregnancy. Risk factors for RhD immunization were compared with population data. Main outcomes measures: Risk factors for FMH and subsequently RhD immunization, prevalence of RhD immunizations. Results: The prevalence of newly detected RhD immunizations was 0.31% (79/25,170) of all RhD-negative pregnant women in the Netherlands. After exclusion, 193 women remained. Significant risk factors found in the group of 113 parous women (previous pregnancy >16 weeks, RhD positive child) were; caesarean section (CS) (OR 1.7, 95% CI 1.1-2.6), perinatal death (OR 3.5, 95% CI 1.1-10.9), gestational age over 42 weeks (OR 6.1, 95% CI 2.2-16.6), postnatal bleeding (>1000mL) (OR 2.0 95% CI 1.1-3.6), surgical removal of the placenta (SRP) (OR 4.3, 95% CI 2.0-9.3). The miscarriage rate in the group of women without a previous RhD positive child was significantly higher than in the Dutch population (35% vs 12.5% p<0.001). Conclusion: Complicated deliveries, including cases of major bleeding and surgical interventions (CS, SRP) need to be recognized as risk factor, requiring determination of FMH volume and adjustment of RhIg dosing. Miscarriage may be an additional risk factor for RhD immunization, requiring further studies. Funding: This research was partly funded by a grant from Sanquin Amsterdam.

Peer review status:UNDER REVIEW

08 Jul 2021Submitted to BJOG: An International Journal of Obstetrics and Gynaecology
14 Jul 2021Assigned to Editor
14 Jul 2021Submission Checks Completed
21 Jul 2021Reviewer(s) Assigned